🇺🇸 FDA
Patent

US 10294477

Compositions and methods for modulating PKK expression

granted A61PA61P11/00A61P29/00

Quick answer

US patent 10294477 (Compositions and methods for modulating PKK expression) held by Ionis Pharmaceuticals, Inc. expires Mon May 16 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Ionis Pharmaceuticals, Inc.
Grant date
Tue May 21 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 16 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61P, A61P11/00, A61P29/00, A61P43/00, A61P7/02